This activity series presents the common challenges of diagnosing and managing progressive fibrotic interstitial lung disease subtypes of IPF and SSc-ILD . There is at present no cure for IPF or SSc-ILD and existing treatments focus on delaying disease progression, controlling symptoms and preventing complications.
Wondering if you should alter medications for your patients with severe asthma? The activity now includes an important update on how to manage patients with severe asthma during COVID-19!
Learn the latest recommendations about NSAIDs, steroids and nebulizers for patients with asthma and COVID-19.